177 related articles for article (PubMed ID: 34903110)
1. Turkish and Moroccan Dutch women's views of using a self-sampling kit for human papillomavirus testing as a tool for cervical cancer screening: What are the barriers and the motivators?
Hilverda F; Fissers K; van den Broek T
Womens Health (Lond); 2021; 17():17455065211065873. PubMed ID: 34903110
[TBL] [Abstract][Full Text] [Related]
2. Decision-making, barriers, and facilitators regarding cervical cancer screening participation among Turkish and Moroccan women in the Netherlands: a focus group study.
Hamdiui N; Marchena E; Stein ML; van Steenbergen JE; Crutzen R; van Keulen HM; Reis R; van den Muijsenbergh METC; Timen A
Ethn Health; 2022 Jul; 27(5):1147-1165. PubMed ID: 33412893
[No Abstract] [Full Text] [Related]
3. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
Vahabi M; Lofters A
BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
[TBL] [Abstract][Full Text] [Related]
4. Impact of an educational intervention on women's knowledge and acceptability of human papillomavirus self-sampling: a randomized controlled trial in Cameroon.
Sossauer G; Zbinden M; Tebeu PM; Fosso GK; Untiet S; Vassilakos P; Petignat P
PLoS One; 2014; 9(10):e109788. PubMed ID: 25333793
[TBL] [Abstract][Full Text] [Related]
5. Ethnographic study of the barriers and facilitators to implementing human papillomavirus (HPV) self-sampling as a primary screening strategy for cervical cancer among Inuit women of Nunavik, Northern Quebec.
Gamelin R; Hébert M; Tratt E; Brassard P
Int J Circumpolar Health; 2022 Dec; 81(1):2032930. PubMed ID: 35166191
[TBL] [Abstract][Full Text] [Related]
6. Reactions of women underscreened for cervical cancer who received unsolicited human papillomavirus self-sampling kits.
Malone C; Tiro JA; Buist DS; Beatty T; Lin J; Kimbel K; Gao H; Thayer C; Miglioretti DL; Winer RL
J Med Screen; 2020 Sep; 27(3):146-156. PubMed ID: 31744374
[TBL] [Abstract][Full Text] [Related]
7. Community cervical cancer screening: Barriers to successful home-based HPV self-sampling in Dabat district, North Gondar, Ethiopia. A qualitative study.
Megersa BS; Bussmann H; Bärnighausen T; Muche AA; Alemu K; Deckert A
PLoS One; 2020; 15(12):e0243036. PubMed ID: 33306681
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Acceptability and Uptake of HPV Self-Sampling Amongst Women Under- or Never-Screened for Cervical Cancer in Toronto (Ontario, Canada): An Intervention Study Protocol.
Lofters A; Devotta K; Prakash V; Vahabi M
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501703
[TBL] [Abstract][Full Text] [Related]
9. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
10. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
Wong EL; Cheung AW; Wong AY; Chan PK
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
[No Abstract] [Full Text] [Related]
11. Preferred Location for Human Papillomavirus Self-Sampling for Cervical Cancer Screening.
Liebermann E; Fontenot HB; Lim E; Matsunaga M; Zimet G; Allen JD
J Obstet Gynecol Neonatal Nurs; 2023 Sep; 52(5):364-373. PubMed ID: 37355248
[TBL] [Abstract][Full Text] [Related]
12. Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial.
Fujita M; Nagashima K; Shimazu M; Suzuki M; Tauchi I; Sakuma M; Yamamoto S; Hanaoka H; Shozu M; Tsuruoka N; Kasai T; Hata A
PLoS One; 2023; 18(6):e0286909. PubMed ID: 37289798
[TBL] [Abstract][Full Text] [Related]
13. Facilitators and Barriers to HPV Self-Sampling as a Cervical Cancer Screening Option among Women Living with HIV in Rural Uganda.
Nyabigambo A; Mayega RW; Hlongwana K; Ginindza TG
Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297609
[No Abstract] [Full Text] [Related]
14. Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study.
Bertucci M; Bonnet E; Satger L; Kreiche A; Chappert JL; Loy-Morel S; Segondy M; Daurès JP; Boulle N
Women Health; 2021 Jan; 61(1):83-94. PubMed ID: 33106125
[TBL] [Abstract][Full Text] [Related]
15. Uptake and acceptability of human papillomavirus self-sampling in rural and remote aboriginal communities: evaluation of a nurse-led community engagement model.
Dutton T; Marjoram J; Burgess S; Montgomery L; Vail A; Callan N; Jacob S; Hawkes D; Saville M; Bailey J
BMC Health Serv Res; 2020 May; 20(1):398. PubMed ID: 32393243
[TBL] [Abstract][Full Text] [Related]
16. Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program.
Smith LW; Khurshed F; van Niekerk DJ; Krajden M; Greene SB; Hobbs S; Coldman AJ; Franco EL; Ogilvie GS
BMC Public Health; 2014 Oct; 14():1060. PubMed ID: 25303975
[TBL] [Abstract][Full Text] [Related]
17. The development of a culturally sensitive educational video: How to facilitate informed decisions on cervical cancer screening among Turkish- and Moroccan-Dutch women.
Hamdiui N; Bouman MPA; Stein ML; Crutzen R; Keskin D; Afrian A; van Steenbergen JE; van den Muijsenbergh METC; Timen A
Health Expect; 2022 Oct; 25(5):2377-2385. PubMed ID: 35866200
[TBL] [Abstract][Full Text] [Related]
18. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.
Ketelaars PJW; Bosgraaf RP; Siebers AG; Massuger LFAG; van der Linden JC; Wauters CAP; Rahamat-Langendoen JC; van den Brule AJC; IntHout J; Melchers WJG; Bekkers RLM
Prev Med; 2017 Aug; 101():96-101. PubMed ID: 28579497
[TBL] [Abstract][Full Text] [Related]
19. Perceived barriers to cervical cancer screening and motivators for at-home human papillomavirus self-sampling during the COVID-19 pandemic: Results from a telephone survey.
Parker S; Deshmukh AA; Chen B; Lairson DR; Daheri M; Vernon SW; Montealegre JR
Elife; 2023 May; 12():. PubMed ID: 37232493
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus self-sampling: A tool in cancer prevention and sexual health promotion.
Mamo L; Pérez AE; Rios L
Sociol Health Illn; 2022 Jan; 44(1):218-235. PubMed ID: 34904724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
